logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
L

Lorenzo Falchi

Memorial Sloan Kettering Cancer Center
H指数:29
被引数:3,500

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

First-line treatment with epcoritamab in combination with bendamustine plus rituximab induces sustained remissions beyond 3 years in patients with follicular lymphoma

使用epcoritamab联合 bendamustine和rituximab的一线治疗在滤泡性淋巴瘤患者中诱导了超过3年的持续缓解

HemaSphere
IF14.6
2026-08-050
OAAI
Umberto Vitolo; Lorenzo Falchi; Per-Ola Andersson; Marcel Nijland; Fritz Offner; Sylvia Snauwaert; Jacob H. Christensen; Michael R. Clausen; Alexander Fosså; Pilar G. Prieto; Eliza A. Hawkes; Judit M. Jørgensen; Yasmin H. Karimi; Catharina Lewerin; Joost S. P. Vermaat; Björn E. Wahlin; Poliana Patah; Christopher Morehouse; Malene Risum; Zhu Li; Jennifer Marek; Joshua D. Brody
MRD-negativity by PBMCs and ctDNA confirms deep and durable responses following epcoritamab monotherapy in R/R FL

通过PBMCs和ctDNA评估的微小残留病阴性证实了epcoritamab单药治疗在复发/难治性滤泡性淋巴瘤中的深度和持久缓解

Blood Advances
IF7.1
2026-07-140
OA
Işıl Altıntaş; Christopher Morehouse; Elena Favaro; Ali Rana; John Karavitis; Edith Szafer-Glusman; Kevin Zhao; Kim Linton; Alexey Danilov; Ann S. LaCasce; Lorenzo Falchi; Jessica Okosun; Tahamtan Ahmadi; Mark Fereshteh; Maria Jure-Kunkel; David Soong; Andrew J. Steele
Clinical outcomes, patterns of relapse and molecular landscape of advanced stage High Grade B-cell Lymphoma

晚期高级别B细胞淋巴瘤的临床结局、复发模式和分子景观

Blood Advances
IF7.1
2026-07-130
OA
Sean E. Healton; Manik Uppal; Pallavi Galera; Efrat Luttwak; Alfredo Rivas-Delgado; Alexander P. Boardman; Philip C. Caron; Kevin David; Zachary Epstein-Peterson; Lorenzo Falchi; Paola Ghione; Paul Hamlin; Steven M. Horwitz; Andrew M. Intlekofer; William Johnson; Anita Kumar; Alison Moskowitz; Ariela Noy; M. Lia Palomba; Raphael Steiner
Prognostic factors and survival outcomes in relapsed/refractory aggressive B-cell lymphomas treated with epcoritamab

复发/难治性侵袭性B细胞淋巴瘤接受epcoritamab治疗后的预后因素和生存结局

Blood Advances
IF7.1
2026-06-090
OAAI
Allison M. Bock; Lei Feng; Ayushi Chauhan; Lorenzo Falchi; Reid Merryman; Sonia Godbole; Swetha K. Thiruvengadam; Andrew P. Jallouk; Ajay Major; Chris D’Angelo; Amy Ayers; Kelsey Baron; Omnia M. Farahat; Geoff Shouse; Alexey Danilov; Steven Bair; Matthew Lunning; Shakthi Bhaskar; Alex F. Herrera; Yazeed Sawalha
CD19-CD28 costimulatory bispecific antibody plus glofitamab in R/R B-NHL: a phase 1 dose-escalation study

CD19-CD28共刺激双特异性抗体联合glofitamab在复发/难治性B-NHL中的I期剂量递增研究

Blood Advances
IF7.1
2026-01-010
OAAI
Michael John Dickinson; Koorosh Korfi; Martin Hutchings; Franck Morschhauser; Carmelo Carlo‐Stella; Lorenzo Falchi; Paolo Fabrizio Caimi; Natalie Dimier; Lance Smith; Matt Whayman; Johannes Sam; Abiraj Keelara; Candice Jamois; Sabine Wilson; Zhiwen Jiang; Jeremy Gallien; Iris Martinez Quetglas; Heather J. Hinton; Isabel Prieto González-Albo; Francesca Michielin; Katharina Lechner; Giuseppe Gritti
Two decades of single-institution data reveal rare longterm survivors of relapsed/refractory Burkitt lymphoma

二十年单机构数据揭示复发/难治性伯基特淋巴瘤的罕见长期生存者

Haematologica
IF7.9
2026-01-011
OA
Molla, Rabeya; Bantilan, Kurt; Berman, Ellin; Caron, Philip; Falchi, Lorenzo; Hamlin, Paul; Horwitz, Steven; Intlekofer, Andrew; Kumar, Anita; Lue, Jennifer; Moskowitz, Alison; Owens, Colette; Palomba, Maria Lia; Dahi, Parastoo Bahrami; Salles, Gilles; Vardhana, Santosha; Shah, Gunjan; Zelenetz, Andrew; Johnson, William; Noy, Ariela
Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3 trial

Epcoritamab、lenalidomide和rituximab与lenalidomide和rituximab治疗复发或难治性滤泡性淋巴瘤的比较（EPCORE FL-1）：一项全球性、开放标签、随机、III期临床试验

The Lancet
IF97.3
2025-12-070
OAAI
Lorenzo Falchi; Marcel Nijland; Huiqiang Huang; Kim M Linton; John F Seymour; Rong Tao; Michal Kwiatek; Abel Costa; Theodoros P Vassilakopoulos; Richard Greil; Ana Jiménez-Ubieto; Shane A Gangatharan; Ohad Benjamini; Catherine Thieblemont; Alessandra Tucci; Anna Elinder-Camburn; Arpad Illes; Jan Novak; Miguel A Pavlovsky; Andrew McDonald
Late hematologic toxicity after CAR T-cell therapy in large B-cell lymphoma: incidence, risk factors, and clinical impact

大B细胞淋巴瘤中CAR T细胞疗法后的晚期血液学毒性：发生率、危险因素及临床影响

Bone Marrow Transplantation
IF5.2
2025-11-180
PRE
Magdalena Corona; Samantha Brown; Kai Rejeski; Jessica R. Flynn; Sean M. Devlin; Sandeep Raj; Alejandro Luna de Abia; Richard J. Lin; Michael Scordo; Gunjan L. Shah; M. Lia Palomba; Alexander P. Boardman; Lorenzo Falchi; Jennifer Lue; Gilles Salles; Jae Park; Sergio A. Giralt; Miguel-Angel Perales; Roni Shouval; Parastoo B. Dahi
Patterns and safety of glucocorticosteroid use following CD19 CAR-T therapy for large B-cell lymphoma

CD19 CAR-T疗法后大B细胞淋巴瘤患者糖皮质激素使用模式与安全性

HEMASPHERE
IF14.6
2025-11-010
OAAI
Luttwak, Efrat; Nemirovsky, David; Devlin, Sean M.; Boardman, Alexander P.; Cassanello, Giulio; Corona, Magdalena; Luan, Danny; Dahi, Parastoo B.; Abia, Alejandro Luna De; Falchi, Lorenzo; Landego, Ivan; Lin, Richard J.; Lue, Jeniffer K.; Palomba, Lia M.; Park, Jae H.; Raj, Sandeep S.; Rejeski, Kai; Rivas Delgado, Alfredo; Scordo, Michael; Tomas, Ana Alarcon; Shah, Gunjan L.; Perales, Miguel-angel; Salles, Gilles; Shouval, Roni
Fixed-Duration Epcoritamab Plus R2 Drives Favorable Outcomes in Relapsed or Refractory Follicular Lymphoma

固定疗程的Epcoritamab联合R2方案可改善复发或难治性滤泡性淋巴瘤患者的预后。

Blood
IF23.1
2025-09-100
OAAI
Lorenzo Falchi; Anna Sureda; Sirpa Leppä; Joost S.P. Vermaat; Marcel Nijland; Jacob Haaber Christensen; Sven de Vos; Harald Holte; Reid W. Merryman; Pieternella J. Lugtenburg; Pau Abrisqueta; Kim M. Linton; Gauri Sunkersett; Daniela Hoehn; Ali Rana; Aqeel Abbas; Jennifer Marek; Yi Hao; Andrew J. Steele; Christopher Morehouse; Martin Hutchings; David Belada
Treatment outcomes and CNS relapse risk in patients with primary cutaneous DLBCL, leg-type in the rituximab era

利妥昔单抗时代原发性皮肤弥漫大B细胞淋巴瘤，腿型的治疗效果和CNS复发风险

Blood Cancer Journal
IF11.6
2025-08-290
OAAI
Giulio Cassanello; Esther Drill; Annie Qiu; Mark D. Ewalt; Paul Hamlin; Steven M. Horwitz; Erel Joffe; Anita Kumar; Alison J. Moskowitz; Ariela Noy; Colette Owens; Maria Lia Palomba; Andrew D. Zelenetz; Ahmet Dogan; Klaus J. Busam; Joachim Yahalom; Gilles Salles; Matthew J. Matasar; Lorenzo Falchi
Comparative real-world outcomes of CD19-directed CAR T-cell therapies in large B-cell lymphoma

CD19靶向CAR T细胞疗法在大型B细胞淋巴瘤中的比较真实世界结果

Blood Advances
IF7.1
2025-08-190
OAAI
Xavier Deschênes-Simard; Maria Bromberg; Sean M. Devlin; Mithat Gonen; Ofrat Beyar-Katz; Andrew Ip; Ronit Marcus; Abraham Avigdor; Annamaria Ballweg; Emma Rabinovich; Mohammad Alhomoud; Alfredo Rivas Delgado; Magdalena Corona De Lapuerta; Alejandro Luna De Abia; Maria Lia Palomba; Gunjan L. Shah; Richard Lin; Alexander P. Boardman; Lorenzo Falchi; Jennifer Lue; Gilles Salles; Miguel-Angel Perales; Roni Shouval; Parastoo B. Dahi; Michael Scordo
Humoral vaccine responses following Chimeric Antigen Receptor T-cell therapy for hematological malignancies

嵌合抗原受体T细胞疗法治疗血液系统恶性肿瘤后的体液疫苗反应

Blood Cancer Journal
IF11.6
2025-07-020
OAAI
Sigrun Einarsdottir; Stephanie Lobaugh; Danny Luan; Marina Gomez-Llobell; Padmapriya Subramanian; Sean Devlin; David Chung; Parastoo B. Dahi; Lorenzo Falchi; Sergio Giralt; Heather Landau; Alexander M. Lesokhin; Richard Lin; Jennifer Lue; Sham Mailankody; M. Lia Palomba; Jae H. Park; Gilles Salles; Michael Scordo; Silvia Escribano-Serrat; Jaime Sanz; Kai Rejeski; Roni Shouval; Saad Usmani; Miguel-Angel Perales; Gunjan Shah; Zainab Shahid
Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab inpatients with relapsed/refractory large B-cell lymphoma

地塞米松与 glofitamab 预治疗中替代糖皮质激素方案相比，可降低大B细胞淋巴瘤复发/难治性患者细胞因子释放综合征的发生频率和强度。

HAEMATOLOGICA
IF7.9
2024-11-280
OA
Falchi, Lorenzo; Hutchings, Martin; Carlo-Stella, Carmelo; Morschhauser, Franck; Dickinson, Michael; Cartron, Guillaume; Khan, Cyrus; Tani, Monica; Martinez-Lopez, Joaquin; Bartlett, Nancy L.; Salar, Antonio; Brody, Joshua D.; Berthier, Aurelien; Kallemeijn, Martine; Relf, James; Tchaleu, Fabiola Bene; Lundberg, Linda; Bachy, Emmanuel

研究方向

暂未获取到该数据
G
Gilles Salles
H 指数:129论文数:1,725被引数:7.9万
A
Ariela Noy
H 指数:62论文数:432被引数:1.3万
A
Andrew D. Zelenetz
H 指数:96论文数:761被引数:4.2万
P
Paul A. Hamlin
H 指数:47论文数:358被引数:8,175
S
Steven M. Horwitz
H 指数:69论文数:550被引数:1.9万
M
Michael Scordo
H 指数:37论文数:524被引数:5,856
A
Alison J. Moskowitz
H 指数:49论文数:460被引数:9,820
J
Jennifer Kimberly Lue
H 指数:17论文数:157被引数:1,599
P
Philip Caron
H 指数:21论文数:156被引数:1,956
A
Anita Kumar
H 指数:37论文数:311被引数:5,328